Changes of polyphosphoinositides, lysophospholipid, and free fatty acids in transient cerebral ischemia of rat brain

1990 ◽  
Vol 12 (3) ◽  
pp. 215-228 ◽  
Author(s):  
Hiroyuki Kinouchi ◽  
Shigeki Imaizumi ◽  
Takashi Yoshimoto ◽  
Hirotaka Yamamoto ◽  
Masakichi Motomiya
1982 ◽  
Vol 245 (2) ◽  
pp. 307-316 ◽  
Author(s):  
Shinichi Yoshida ◽  
Kouichi Abe ◽  
Raul Busto ◽  
Brant D. Watson ◽  
Kyuya Kogure ◽  
...  

Metabolites ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. 204 ◽  
Author(s):  
Jesper F. Havelund ◽  
Kevin H. Nygaard ◽  
Troels H. Nielsen ◽  
Carl-Henrik Nordström ◽  
Frantz R. Poulsen ◽  
...  

Cerebral micro-dialysis allows continuous sampling of extracellular metabolites, including glucose, lactate and pyruvate. Transient ischemic events cause a rapid drop in glucose and a rise in lactate levels. Following such events, the lactate/pyruvate (L/P) ratio may remain elevated for a prolonged period of time. In neurointensive care clinics, this ratio is considered a metabolic marker of ischemia and/or mitochondrial dysfunction. Here we propose a novel, sensitive microdialysis liquid chromatography-mass spectrometry (LC-MS) approach to monitor mitochondrial dysfunction in living brain using perfusion with 13C-labeled succinate and analysis of 13C-labeled tricarboxylic acid cycle (TCA) intermediates. This approach was evaluated in rat brain using malonate-perfusion (10–50 mM) and endothelin-1 (ET-1)-induced transient cerebral ischemia. In the malonate model, the expected changes upon inhibition of succinate dehydrogenase (SDH) were observed, i.e., an increase in endogenous succinate and decreases in fumaric acid and malic acid. The inhibition was further elaborated by incorporation of 13C into specific TCA intermediates from 13C-labeled succinate. In the ET-1 model, increases in non-labeled TCA metabolites (reflecting release of intracellular compounds) and decreases in 13C-labeled TCA metabolites (reflecting inhibition of de novo synthesis) were observed. The analysis of 13C incorporation provides further layers of information to identify metabolic disturbances in experimental models and neuro-intensive care patients.


1997 ◽  
Vol 237 ◽  
pp. S25
Author(s):  
H. Heller ◽  
J. Deutsch ◽  
A.D. Purdon ◽  
S.I. Rapoport ◽  
M. Horowitz ◽  
...  

Glia ◽  
2018 ◽  
Vol 67 (2) ◽  
pp. 232-245 ◽  
Author(s):  
Wenson D. Rajan ◽  
Bartosz Wojtas ◽  
Bartlomiej Gielniewski ◽  
Anna Gieryng ◽  
Malgorzata Zawadzka ◽  
...  

1998 ◽  
Vol 55 (2) ◽  
pp. 341-344 ◽  
Author(s):  
Wulf Paschen ◽  
Thomas Linden ◽  
Jens Doutheil

1971 ◽  
Vol 18 (8) ◽  
pp. 1387-1393 ◽  
Author(s):  
N. G. Bazán ◽  
Haydeé E. P. Bazán ◽  
Wendy G. Kennedy ◽  
C. D. Joel

Stroke ◽  
1989 ◽  
Vol 20 (7) ◽  
pp. 904-910 ◽  
Author(s):  
R Busto ◽  
M Y Globus ◽  
W D Dietrich ◽  
E Martinez ◽  
I Valdés ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document